Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Human Menopausal Gonadotropin Treatment for Sperm DNA Fragmentation in Men With Idiopathic Infertility: A Prospective Controlled Study

NCT07873502 is registered in ClinicalTrials.gov with Jinling Hospital, China as lead sponsor.

NCT NCT07873502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07873502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Human Menopausal Gonadotropin Treatment for Sperm DNA Fragmentation in Men With Idiopathic Infertility: A Prospective Controlled Study
Lead sponsor
Jinling Hospital, China
Phase
Phase 1
Overall status
Completed
Start date
July 2, 2025
Completion date
August 31, 2026
Enrollment
114 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sperm dna fragmentation